Liu Zheng, Deng Wen, Xu Wenlin, Ye Linlin, Rao Zhihui
Department of Respiratory, Children's Hospital of Chongqing Medical University, Chongqing, China.
Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Front Med (Lausanne). 2025 Aug 26;12:1624256. doi: 10.3389/fmed.2025.1624256. eCollection 2025.
To explore the dynamic changes in pulmonary and immune function among children with Mycoplasma pneumoniae pneumonia (MPP) and evaluate their value in disease severity stratification and prognosis prediction.
A retrospective cohort of 225 pediatric patients with varying degrees of MPP severity and disease course was analyzed. Lung function and immunological indices were measured and compared across groups.
Children with MPP exhibited significant impairments in pulmonary function and alterations in immune profiles compared to controls. These changes were associated with both disease severity and recovery status.
Pulmonary and immune function markers may serve as useful indicators for assessing severity and recovery in pediatric MPP. Their clinical application could improve individualized management strategies.
探讨肺炎支原体肺炎(MPP)患儿肺功能和免疫功能的动态变化,并评估其在疾病严重程度分层和预后预测中的价值。
对225例不同严重程度和病程的MPP患儿进行回顾性队列分析。测量并比较各组的肺功能和免疫指标。
与对照组相比,MPP患儿的肺功能有显著损害,免疫谱也有改变。这些变化与疾病严重程度和恢复状态均相关。
肺功能和免疫功能指标可作为评估小儿MPP严重程度和恢复情况的有用指标。它们的临床应用可改善个体化管理策略。